Literature DB >> 22108106

Incidence of postoperative endophthalmitis after immediate sequential bilateral cataract surgery.

Steve A Arshinoff1, Paul A Bastianelli.   

Abstract

PURPOSE: To determine a best estimate of the incidence of endophthalmitis after immediately sequential bilateral cataract surgery (ISBCS) and assess the benefit of prophylactic intracameral antibiotics.
SETTING: Eye Foundation of Canada, Toronto, Ontario, Canada.
DESIGN: Cohort study.
METHODS: A detailed literature search was performed to obtain recently reported frequencies of postoperative endophthalmitis with or without the use of prophylactic intracameral antibiotics. Members of the International Society of Bilateral Cataract Surgeons were surveyed. The data were collected to determine the results of unilateral and bilateral cataract surgeries performed by experienced bilateral cataract surgeons. The data were statistically analyzed.
RESULTS: In recently published European prophylactic intracameral cephalosporin studies, the incidence of postoperative endophthalmitis after unilateral cataract surgery weight-averaged to 1 in 331 (0.3%) without prophylactic intracameral antibiotics and to 1 in 1977 (0.05%) with prophylactic intracameral antibiotics, whereas studies in the United States using only topical antibiotics reported infection rates as low as 0.028%. Four cases of bilateral simultaneous endophthalmitis after ISBCS have been reported in the past 60 years, all with breaches of aseptic protocol. No bilateral simultaneous endophthalmitis occurred in the 95 606 ISBCS cases collected. The overall rate of postoperative endophthalmitis after ISBCS was 1 in 5759. Infection rates were significantly reduced with intracameral antibiotics to 1 in 14 352 cases.
CONCLUSIONS: The risk for postoperative endophthalmitis in ISBCS appears to be at least as low as and possibly lower than published rates for unilateral surgery, particularly when recommended precautions are taken. Intracameral antibiotics significantly reduced the risk for postoperative endophthalmitis.
Copyright © 2011 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22108106     DOI: 10.1016/j.jcrs.2011.06.036

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  38 in total

1.  Long-term effects of intracameral moxifloxacin.

Authors:  Kazuki Matsuura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-06-07       Impact factor: 3.117

2.  Pathogens and antibiotic sensitivities in endophthalmitis.

Authors:  Geraldine R Slean; Neal H Shorstein; Liyan Liu; John F Paschal; Kevin L Winthrop; Lisa J Herrinton
Journal:  Clin Exp Ophthalmol       Date:  2017-01-31       Impact factor: 4.207

3.  Response to Tatham and Brookes.

Authors:  C Claoué; S Arshinoff; B Johansson
Journal:  Eye (Lond)       Date:  2012-11-16       Impact factor: 3.775

4.  Reply to Claoué et al.

Authors:  A Tatham; J L Brookes
Journal:  Eye (Lond)       Date:  2012-11-16       Impact factor: 3.775

5.  Comparison between intracameral moxifloxacin administration methods by assessing intraocular concentrations and drug kinetics.

Authors:  Kazuki Matsuura; Chikako Suto; Junsuke Akura; Yoshitsugu Inoue
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-04-02       Impact factor: 3.117

6.  Comparative analysis of the safety and efficacy of intracameral cefuroxime, moxifloxacin and vancomycin at the end of cataract surgery: a meta-analysis.

Authors:  Randy C Bowen; Andrew Xingyu Zhou; Sailaja Bondalapati; Thomas W Lawyer; Karisa B Snow; Patrick R Evans; Tyler Bardsley; Mary McFarland; Matthew Kliethermes; Dallas Shi; Christina A Mamalis; Tom Greene; Christopher J Rudnisky; Balamurali Krishna Ambati
Journal:  Br J Ophthalmol       Date:  2018-01-11       Impact factor: 4.638

7.  Safety of undiluted intracameral moxifloxacin without postoperative topical antibiotics in cataract surgery.

Authors:  Andrew Xingyu Zhou; Wyatt Boyer Messenger; Steven Sargent; Balamurali Krishna Ambati
Journal:  Int Ophthalmol       Date:  2015-11-14       Impact factor: 2.031

8.  Immediate Sequential Bilateral Pediatric Vitreoretinal Surgery: An International Multicenter Study.

Authors:  Yoshihiro Yonekawa; Wei-Chi Wu; Shunji Kusaka; Joshua Robinson; Daishi Tsujioka; Kai B Kang; Michael J Shapiro; Tapas R Padhi; Lubhani Jain; Jonathan E Sears; Ajay E Kuriyan; Audina M Berrocal; Polly A Quiram; Amanda E Gerber; R V Paul Chan; Karyn E Jonas; Sui Chien Wong; C K Patel; Ashkan M Abbey; Rand Spencer; Michael P Blair; Emmanuel Y Chang; Thanos D Papakostas; Demetrios G Vavvas; Robert A Sisk; Philip J Ferrone; Robert H Henderson; Karl R Olsen; M Elizabeth Hartnett; Felix Y Chau; Shizuo Mukai; Timothy G Murray; Benjamin J Thomas; P Anthony Meza; Kimberly A Drenser; Michael T Trese; Antonio Capone
Journal:  Ophthalmology       Date:  2016-05-22       Impact factor: 12.079

Review 9.  Recurring themes during cataract assessment and surgery.

Authors:  Shruti Chandra; Sobha Sivaprasad; Paul G Ursell; Khayam Naderi; David O'Brart; Amar Alwitry; Mayank A Nanavaty
Journal:  Eye (Lond)       Date:  2021-04-29       Impact factor: 4.456

10.  Endophthalmitis Rate in Immediately Sequential versus Delayed Sequential Bilateral Cataract Surgery within the Intelligent Research in Sight (IRIS®) Registry Data.

Authors:  Megan Lacy; Timothy-Paul H Kung; Julia P Owen; Ryan T Yanagihara; Marian Blazes; Suzann Pershing; Leslie G Hyman; Russell N Van Gelder; Aaron Y Lee; Cecilia S Lee
Journal:  Ophthalmology       Date:  2021-07-13       Impact factor: 14.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.